| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Werner J. Pichler | Q43088181 |
| Marianne Lerch | Q61890678 | ||
| P2093 | author name string | Monika Keller | |
| Andreas Beeler | |||
| Anna Zawodniak | |||
| Sinforiano Posadas | |||
| Basil Gerber | |||
| Daphné Schmid | |||
| Zoi Spanou | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17-25 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Allergology International | Q15762784 |
| P1476 | title | Pharmacological interaction of drugs with immune receptors: the p-i concept | |
| P478 | volume | 55 |
| Q26744352 | A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements |
| Q42966589 | A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury |
| Q28538078 | Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses |
| Q30235268 | Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics |
| Q42072504 | Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study |
| Q47703247 | Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking |
| Q51695272 | Amoxicillin haptenates intracellular proteins that can be transported in exosomes to target cells. |
| Q59349191 | Antibiotic Allergy in Pediatrics |
| Q92570447 | Antimicrobial Desensitization: A Review of Published Protocols |
| Q34075812 | Antiviral drug allergy. |
| Q36740238 | Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population |
| Q26744628 | Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations |
| Q49315568 | Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights. |
| Q28660812 | Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells |
| Q57300409 | Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02 |
| Q24626941 | Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing |
| Q38534421 | Clinical Role of Human Leukocyte Antigen in Health and Disease. |
| Q27679355 | Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire |
| Q26822023 | Drug hypersensitivity reactions targeting the skin in dogs and cats |
| Q53266106 | Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. |
| Q52346835 | Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention. |
| Q37617470 | Effector and regulatory mechanisms in allergic contact dermatitis. |
| Q26800980 | Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. |
| Q34209489 | Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis |
| Q38168331 | Female gender as a susceptibility factor for drug-induced liver injury |
| Q27692095 | Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. |
| Q37963995 | HLA alleles and drug hypersensitivity reactions |
| Q90916419 | HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project |
| Q52837404 | HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis. |
| Q38949927 | HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions. |
| Q47320133 | HLAs: Key regulators of T-cell-mediated drug hypersensitivity. |
| Q37510953 | Immune mediation of hypersensitivity adverse drug reactions: implications for therapy |
| Q42289978 | In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01. |
| Q37605792 | In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review |
| Q37754599 | In vitro tests of T cell-mediated drug hypersensitivity. |
| Q82622841 | Looking ahead in dermatology: skin and allergy |
| Q37464963 | MHC restriction and allogeneic immune responses. |
| Q59281741 | Mechanisms in cutaneous drug hypersensitivity reactions |
| Q64241600 | Mechanisms of hypersensitivity reactions induced by drugs |
| Q38805641 | Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity |
| Q83690300 | Oral hairy leukoplakia in a patient on long-term anticonvulsant treatment with lamotrigine |
| Q57223243 | Personalized medicine for HLA-associated drug-hypersensitivity reactions |
| Q33819062 | PharmGKB summary: abacavir pathway |
| Q35168561 | PharmGKB summary: very important pharmacogene information for human leukocyte antigen B. |
| Q38422218 | Pharmacogenetic considerations in the treatment of gout |
| Q38217627 | Pharmacogenetics of antiepileptic drug-induced hypersensitivity |
| Q34118186 | Pharmacogenetics of drug hypersensitivity |
| Q37763930 | Pharmacogenetics of toxic epidermal necrolysis. |
| Q38036150 | Pharmacogenomics of adverse drug reactions: implementing personalized medicine |
| Q30400366 | Pharmacogenomics of off-target adverse drug reactions |
| Q37226687 | Photoaffinity antigens for human gammadelta T cells |
| Q55077637 | Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. |
| Q37121662 | Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. |
| Q41827577 | Recent progress of elucidating the mechanisms of drug hypersensitivity |
| Q39291741 | Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice |
| Q41927200 | Severe Delayed Drug Reactions: Role of Genetics and Viral Infections. |
| Q33852354 | Small molecules as friends and foes of the immune system |
| Q27684560 | Structural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and Autoimmunity |
| Q38689568 | Structural Elements Recognized by Abacavir-Induced T Cells |
| Q38080040 | Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine |
| Q28540335 | Study of protein haptenation by amoxicillin through the use of a biotinylated antibiotic |
| Q27304795 | Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition |
| Q34971993 | T cell-mediated hypersensitivity reactions to drugs |
| Q38033651 | T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction |
| Q37626751 | The HLA-A*31:01 allele: influence on carbamazepine treatment |
| Q90749291 | The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity |
| Q28548544 | The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01 |
| Q38050483 | The structural basis of HLA-associated drug hypersensitivity syndromes |
| Q26745232 | Toxic epidermal necrolysis |
| Q34749889 | Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs |
| Q37836561 | γδ T cell receptor ligands and modes of antigen recognition |
Search more.